Sara Barrambana
Sara Barrambana is a leading researcher at the CNIO, specializing in oncology. She co-authored a pivotal study that achieved complete remission of pancreatic cancer in mice through a triple-drug therapy, marking a significant advancement in cancer treatment and bringing hope for future clinical applications.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Mexico | 1 | 9.00 | 0.15% | +0% | 128,932,753 | 191,011 | $1,200,000 | 1,778$ |
| Guatemala | 1 | 9.00 | 0.09% | +0% | 17,915,568 | 16,482 | $82,000 | 75$ |
| Totals | 2 | 146,848,321 | 207,493 | $1,282,000 | 1,853$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Guatemala:
Sara Barrambana is a lead scientist involved in the development of the new pancreatic cancer therapy.
9
Mexico:
Sara Barrambana is a lead scientist at CNIO involved in the study that successfully eliminated pancreatic cancer in mice.
9